A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
266 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Local Institution - 0318
Chivilcoy, Buenos Aires, Argentina
Active, not recruiting - Local Institution - 0213
Buenos Aires, Buenos Aires F.D., Argentina
Active, not recruiting - Local Institution - 0249
Córdoba, Córdoba Province, Argentina
Active, not recruiting - Local Institution - 0239
Viedma, R, Argentina
Active, not recruiting - Local Institution - 0200
Rosario, Santa Fe Province, Argentina
Active, not recruiting - Local Institution - 0248
S3000epv, Santa Fe Province, Argentina
Completed - Local Institution - 0214
Buenos Aires, Argentina
Active, not recruiting
- Local Institution - 0055
Liverpool, New South Wales, Australia
Active, not recruiting - Local Institution - 0004
Waratah, New South Wales, Australia
Active, not recruiting - Local Institution - 0017
Wollongong, New South Wales, Australia
Active, not recruiting - Local Institution - 0327
Birtinya, Queensland, Australia
Active, not recruiting - Local Institution - 0221
Box Hill, Victoria, Australia
Active, not recruiting - Local Institution - 0002
Melbourne, Victoria, Australia
Active, not recruiting - Local Institution - 0003
Melbourne, Victoria, Australia
Active, not recruiting - Local Institution - 0040
Nedlands, Western Australia, Australia
Active, not recruiting
- Klinik Ottakring
Vienna, State of Vienna, Austria
Recruiting - Universitätsklinikum Krems
Krems, Austria
Recruiting - Local Institution - 0024
Leoben, Austria
Completed - Universitätsklinikum St. Pölten
Sankt Pölten, Austria
Recruiting - Hanusch-Krankenhaus
Vienna, Austria
Recruiting
- Ziekenhuis Oost-Limburg, Campus St.-Jan
Genk, Limburg, Belgium
Recruiting - Uz Gent
Ghent, Oost-Vlaanderen, Belgium
Recruiting - Az Nikolaas
Sint-Niklaas, Oost-Vlaanderen, Belgium
Recruiting - Zna Cadix
Antwerp, Belgium
Recruiting
- Instituto D'Or de Pesquisa E Ensino (idor) - Filial Salvador
Salvador, Estado de Bahia, Brazil
Recruiting - Centro Gaucho Integrado de Oncologia, Hematologia, Ensino E Pesquisa
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Instituto Joinvilense de Hematologia E Oncologia
Joinville, Santa Catarina, Brazil
Recruiting - Hospital Amaral Carvalho
Jaú, São Paulo, Brazil
Recruiting - Americas Centro de Oncologia Integrado
Rio de Janeiro, Brazil
Recruiting - Clínica Médica São Germano S/s Ltda
São Paulo, Brazil
Recruiting - Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
São Paulo, Brazil
Recruiting
- Local Institution - 0225
Greenfield Park, Quebec, Canada
Active, not recruiting - Local Institution - 0174
Montreal, Quebec, Canada
Active, not recruiting - Local Institution - 0222
Québec, Quebec, Canada
Active, not recruiting
- Local Institution - 0329
Santiago, Santiago Metropolitan, Chile
Active, not recruiting - Local Institution - 0387
Santiago, Santiago Metropolitan, Chile
Active, not recruiting - Local Institution - 0332
Viña del Mar, Valparaiso, Chile
Active, not recruiting
- Local Institution - 0062
Beijing, Beijing Municipality, China
Active, not recruiting - Local Institution - 0141
Beijing, Beijing Municipality, China
Completed - Local Institution - 0165
Beijing, Beijing Municipality, China
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Sept 2022
- Primary completion
- 10 Jan 2027
- Completion
- 30 Nov 2033
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 810
- Registry id
- NCT05519085
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.